2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

We investigated changes on 2′-deoxy-2′-[18F]fluoro-D-glucose positron emission tomography ((18)FDG-PET), diffusion-weighted magnetic resonance imaging (DW-MRI), and choline spectroscopy as early markers of cetuximab activity in squamous cell carcinoma of the head and neck (SCCHN). SCCHN patient-deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignion, Lionel, Schmitz, Sandra, Michoux, Nicolas, Caignet, Xavier, Goebbels, Rose-Marie, Bol, Anne, Neveu, Marie-Aline C., Grégoire, Vincent, Duprez, Thierry, Lhommel, Renaud, Amant, Fréderic, Hermans, Els, Jordan, Benedicte F., Machiels, Jean-Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033354/
https://www.ncbi.nlm.nih.gov/pubmed/29983881
http://dx.doi.org/10.18632/oncotarget.25574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033354/
https://www.ncbi.nlm.nih.gov/pubmed/29983881
http://dx.doi.org/10.18632/oncotarget.25574

Ejemplares similares